MCID: ORL015
MIFTS: 43

Oral Squamous Cell Carcinoma

Categories: Cancer diseases, Gastrointestinal diseases, Oral diseases, Rare diseases, Skin diseases

Aliases & Classifications for Oral Squamous Cell Carcinoma

MalaCards integrated aliases for Oral Squamous Cell Carcinoma:

Name: Oral Squamous Cell Carcinoma 12 74 52 15 17
Squamous Cell Carcinoma of Mouth 71
Mouth Squamous Cell Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0050866
UMLS 71 C0585362

Summaries for Oral Squamous Cell Carcinoma

Disease Ontology : 12 An oral cavity cancer that has material basis in squamous cells.

MalaCards based summary : Oral Squamous Cell Carcinoma, also known as squamous cell carcinoma of mouth, is related to squamous cell carcinoma and tongue squamous cell carcinoma. An important gene associated with Oral Squamous Cell Carcinoma is MIR21 (MicroRNA 21), and among its related pathways/superpathways is LncRNA-mediated mechanisms of therapeutic resistance. The drugs Melatonin and Antioxidants have been mentioned in the context of this disorder. Affiliated tissues include lymph node, tongue and bone.

Wikipedia : 74 Squamous cell carcinomas (SCCs), also known as epidermoid carcinomas, comprise a number of different... more...

Related Diseases for Oral Squamous Cell Carcinoma

Diseases related to Oral Squamous Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 319, show less)
# Related Disease Score Top Affiliating Genes
1 squamous cell carcinoma 33.6 UCA1 TUG1 NEAT1 MALAT1 HOTAIR H19
2 tongue squamous cell carcinoma 32.1 UCA1 MIR21 MEG3 MALAT1
3 b-cell lymphoma 31.6 TUG1 MIR21 MALAT1 HOTAIR
4 melanoma 31.4 UCA1 MIR193A MIR137 MIR100 MEG3 MALAT1
5 esophageal cancer 31.3 UCA1 MIR21 MIR193A MIR100 MEG3 MALAT1
6 bladder cancer 31.3 UCA1 TUG1 MIR21 MIR193A MIR100 MEG3
7 lung cancer susceptibility 3 31.2 TUG1 MIR21 MIR193A MEG3 MALAT1 HOTAIR
8 retinitis pigmentosa 11 31.2 UCA1 NEAT1 HOTAIR
9 colorectal cancer 31.1 UCA1 TUG1 NEAT1 MIR21 MIR193A MIR137
10 pancreatic ductal adenocarcinoma 31.1 UCA1 MIR21 MALAT1 HOTAIR H19
11 hepatocellular carcinoma 31.1 UCA1 TUG1 NEAT1 MIR21 MIR193A MIR137
12 nasopharyngeal carcinoma 31.0 NEAT1 MIR21 MIR100 MEG3 MALAT1 HOTAIR
13 osteogenic sarcoma 31.0 UCA1 TUG1 NEAT1 MEG3 MALAT1 HOTAIR
14 leukemia, acute myeloid 31.0 UCA1 TUG1 MIR21 MIR193A MEG3 MALAT1
15 ovarian cancer 31.0 UCA1 TUG1 NEAT1 MIR21 MIR193A MIR100
16 prostate cancer 31.0 UCA1 TUG1 NEAT1 MIR21 MIR100 MEG3
17 thyroid cancer, nonmedullary, 1 30.9 NEAT1 MEG3 MALAT1 HOTAIR H19
18 gastric cancer 30.9 UCA1 TUG1 NEAT1 MIR21 MEG3 MALAT1
19 myeloma, multiple 30.8 UCA1 TUG1 MIR21 MEG3 MALAT1 HOTAIR
20 gallbladder cancer 30.8 UCA1 TUG1 MEG3 MALAT1 HOTAIR H19
21 laryngeal squamous cell carcinoma 30.8 NEAT1 MIR21 MALAT1 HOTAIR H19 CCAT1
22 kidney cancer 30.8 MIR21 MIR193A MEG3 MALAT1 HOTAIR H19
23 glioma 30.8 UCA1 NEAT1 MIR21 MEG3 MALAT1 HOTAIR
24 cervical cancer 30.8 UCA1 TUG1 NEAT1 MIR21 MEG3 MALAT1
25 lung cancer 30.7 UCA1 TUG1 NEAT1 MIR21 MIR193A MIR137
26 renal cell carcinoma, nonpapillary 30.7 UCA1 TUG1 MIR21 MIR193A MALAT1 HOTAIR
27 endometrial cancer 30.6 UCA1 TUG1 NEAT1 MIR193A MEG3 HOTAIR
28 lung squamous cell carcinoma 30.6 TUG1 MEG3 CCAT2 CCAT1
29 pre-eclampsia 30.5 TUG1 MALAT1 HOTAIR H19
30 meningioma, radiation-induced 30.1 MEG3 H19
31 oral cancer 11.4
32 leukoplakia 11.0
33 oral leukoplakia 10.9
34 lichen planus 10.8
35 glioma susceptibility 1 10.8 TUG1 MIR21 MIR137 MEG3 MALAT1 HOTAIR
36 oral lichen planus 10.8
37 oral submucous fibrosis 10.8
38 small cell cancer of the lung 10.8 TUG1 MIR21 MALAT1 HOTAIR CCAT2
39 esophagus squamous cell carcinoma 10.8 TUG1 MEG3 HOTAIR
40 papilloma 10.7
41 squamous cell papilloma 10.7
42 bladder urothelial carcinoma 10.7 UCA1 TUG1 MEG3 MALAT1 HOTAIR
43 cholangiocarcinoma 10.7 UCA1 TUG1 NEAT1 MIR21 MALAT1 H19
44 pituitary adenoma 10.7 MEG3 MALAT1 HOTAIR H19 CCAT2
45 gastric cardia adenocarcinoma 10.7 MEG3 HOTAIR H19
46 tongue carcinoma 10.7
47 functionless pituitary adenoma 10.7 MEG3 HOTAIR
48 astrocytoma 10.7 UCA1 NEAT1 MIR21 HOTAIR H19
49 clear cell renal cell carcinoma 10.7 TUG1 MIR21 MEG3 MALAT1 CCAT2
50 in situ carcinoma 10.7
51 malignant glioma 10.7 TUG1 NEAT1 MEG3 MALAT1 HOTAIR H19
52 triple-receptor negative breast cancer 10.7 MALAT1 HOTAIR
53 prostate disease 10.7 MIR21 MIR193A MEG3 MALAT1 H19
54 tongue disease 10.6 UCA1 MIR21 MIR193A
55 vulva squamous cell carcinoma 10.6 MEG3 MALAT1
56 gastrointestinal system cancer 10.6 MIR21 MIR193A MIR100 MALAT1 HOTAIR H19
57 ovarian epithelial cancer 10.6 CCAT2 CCAT1
58 intrahepatic cholangiocarcinoma 10.6 TUG1 CCAT2 CCAT1
59 thyroid gland cancer 10.6 UCA1 MALAT1 HOTAIR H19
60 verrucous carcinoma 10.6
61 oral cavity cancer 10.6
62 pancreatic cancer 10.6 UCA1 TUG1 NEAT1 MIR21 MIR100 MEG3
63 microvascular complications of diabetes 3 10.6 MIR21 MALAT1
64 mucositis 10.6
65 keratosis 10.6
66 leukemia, chronic myeloid 10.5 UCA1 MEG3 HOTAIR H19
67 severe combined immunodeficiency 10.5
68 bone sarcoma 10.5 MIR21 MIR193A MIR100
69 bone resorption disease 10.5
70 familial adenomatous polyposis 10.5
71 hypereosinophilic syndrome 10.5
72 neutropenia 10.5
73 oral mucosa leukoplakia 10.5
74 herpes simplex 10.5
75 oculopharyngeal muscular dystrophy 10.4
76 47,xyy 10.4
77 48,xyyy 10.4
78 squamous cell carcinoma, head and neck 10.4
79 periodontitis 10.4
80 oropharynx cancer 10.4
81 alcohol use disorder 10.4
82 hypoxia 10.4
83 retinoblastoma 10.4
84 familial retinoblastoma 10.4
85 connective tissue cancer 10.4 MIR21 MIR193A MIR100
86 parkinson disease, late-onset 10.3 NEAT1 MIR21 MALAT1 HOTAIR H19
87 triiodothyronine receptor auxiliary protein 10.3
88 telangiectasis 10.3
89 glioblastoma multiforme 10.3
90 suppressor of tumorigenicity 3 10.3
91 ataxia-telangiectasia 10.3
92 ataxia and polyneuropathy, adult-onset 10.3
93 graft-versus-host disease 10.3
94 proliferative verrucous leukoplakia 10.3
95 fibrosis of extraocular muscles, congenital, 1 10.3
96 persistent mullerian duct syndrome 10.3
97 myiasis 10.3
98 histiocytosis 10.3
99 chronic graft versus host disease 10.3
100 argyria 10.3
101 fanconi anemia, complementation group a 10.2
102 periodontitis, chronic 10.2
103 candidiasis 10.2
104 adenocarcinoma 10.2
105 dysphagia 10.2
106 overgrowth syndrome 10.2
107 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
108 xeroderma pigmentosum, variant type 10.2
109 body mass index quantitative trait locus 1 10.2
110 helix syndrome 10.2
111 adenoid cystic carcinoma 10.2
112 osteonecrosis 10.2
113 bacterial infectious disease 10.2
114 oral candidiasis 10.2
115 vascular disease 10.2
116 stomatitis 10.2
117 breast cancer 10.1
118 insulin-like growth factor i 10.1
119 leukemia, acute lymphoblastic 3 10.1
120 autosomal recessive disease 10.1
121 rickets 10.1
122 brain cancer 10.1
123 thrombocytosis 10.1
124 thrombophilia 10.1
125 fibrosarcoma 10.1
126 adenoma 10.1
127 trichinosis 10.1
128 erythroplakia 10.1
129 fibromatosis 10.1
130 inflammatory myopathy with abundant macrophages 10.1
131 autoimmune disease 10.0
132 polykaryocytosis inducer 10.0
133 tobacco addiction 10.0
134 wilms tumor 1 10.0
135 fanconi anemia, complementation group d2 10.0
136 hyaline fibromatosis syndrome 10.0
137 laurence-moon syndrome 10.0
138 werner syndrome 10.0
139 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.0
140 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
141 melanoma, cutaneous malignant 10 10.0
142 deficiency anemia 10.0
143 exanthem 10.0
144 colorectal adenocarcinoma 10.0
145 fibroma 10.0
146 ameloblastoma 10.0
147 tonsil squamous cell carcinoma 10.0
148 lymphoma 10.0
149 urticaria 10.0
150 thrombocytopenia 10.0
151 cheilitis 10.0
152 cervix carcinoma 10.0
153 gingival overgrowth 10.0
154 skin carcinoma 10.0
155 spindle cell carcinoma 10.0
156 syphilis 10.0
157 papillary squamous carcinoma 10.0
158 pleomorphic adenoma 10.0
159 liver cirrhosis 10.0
160 gingival hypertrophy 10.0
161 keratinizing squamous cell carcinoma 10.0
162 basaloid squamous cell carcinoma 10.0
163 actinomycosis 10.0
164 lip cancer 10.0
165 aphthous stomatitis 10.0
166 actinic cheilitis 10.0
167 candida glabrata 10.0
168 cytokine deficiency 10.0
169 rapidly involuting congenital hemangioma 10.0
170 polyendocrinopathy 10.0
171 alcohol dependence 9.9
172 alzheimer disease 9.9
173 cleft palate, isolated 9.9
174 darier-white disease 9.9
175 cockayne syndrome b 9.9
176 exostoses, multiple, type i 9.9
177 hypercalciuria, absorptive, 2 9.9
178 hypercalcemia, infantile, 1 9.9
179 intussusception 9.9
180 keratitis, hereditary 9.9
181 keratitis-ichthyosis-deafness syndrome, autosomal dominant 9.9
182 li-fraumeni syndrome 9.9
183 medulloblastoma 9.9
184 antigen defined by monoclonal antibody aj9 9.9
185 multicentric carpotarsal osteolysis syndrome 9.9
186 pernicious anemia 9.9
187 phosphoglycoprotein 1 9.9
188 rheumatoid arthritis 9.9
189 trigeminal neuralgia 9.9
190 von hippel-lindau syndrome 9.9
191 whim syndrome 9.9
192 white sponge nevus 1 9.9
193 3-methylcrotonyl-coa carboxylase 1 deficiency 9.9
194 bloom syndrome 9.9
195 chondrosarcoma 9.9
196 chordoma 9.9
197 fanconi anemia, complementation group c 9.9
198 multiple acyl-coa dehydrogenase deficiency 9.9
199 immune deficiency disease 9.9
200 microcephaly 1, primary, autosomal recessive 9.9
201 proteasome-associated autoinflammatory syndrome 1 9.9
202 polycythemia vera 9.9
203 thymoma, familial 9.9
204 wiskott-aldrich syndrome 9.9
205 tubulin, beta 9.9
206 hypogonadotropic hypogonadism 1 with or without anosmia 9.9
207 helicobacter pylori infection 9.9
208 wilms tumor 5 9.9
209 branchiootic syndrome 1 9.9
210 pulmonary disease, chronic obstructive 9.9
211 meningioma, familial 9.9
212 epidermolysis bullosa simplex superficialis 9.9
213 hypertensive nephropathy 9.9
214 li-fraumeni syndrome 2 9.9
215 alzheimer disease 15 9.9
216 smoking as a quantitative trait locus 3 9.9
217 acute promyelocytic leukemia 9.9
218 leukemia, acute lymphoblastic 9.9
219 barrett esophagus 9.9
220 myopathy, tubular aggregate, 2 9.9
221 central centrifugal cicatricial alopecia 9.9
222 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
223 superficial mycosis 9.9
224 orofacial cleft 9.9
225 inflammatory bowel disease 9.9
226 colorectal adenoma 9.9
227 hepatocellular adenoma 9.9
228 salivary gland carcinoma 9.9
229 aphasia 9.9
230 generalized epilepsy with febrile seizures plus 9.9
231 primary microcephaly 9.9
232 osteomyelitis 9.9
233 salivary gland disease 9.9
234 microcephaly 9.9
235 sarcoma 9.9
236 pertussis 9.9
237 respiratory failure 9.9
238 hypoparathyroidism 9.9
239 spinal meningioma 9.9
240 hemopericardium 9.9
241 cardiac tamponade 9.9
242 cauda equina syndrome 9.9
243 pericardial effusion 9.9
244 leukemia 9.9
245 paracoccidioidomycosis 9.9
246 carotid stenosis 9.9
247 gout 9.9
248 eclampsia 9.9
249 anus cancer 9.9
250 toxic shock syndrome 9.9
251 glossitis 9.9
252 hypothyroidism 9.9
253 ichthyosis 9.9
254 cerebral palsy 9.9
255 rectum cancer 9.9
256 hyperinsulinism 9.9
257 chronic mucocutaneous candidiasis 9.9
258 ectodermal dysplasia 9.9
259 dental caries 9.9
260 iron metabolism disease 9.9
261 granular cell tumor 9.9
262 basal cell carcinoma 9.9
263 hemangioma 9.9
264 agammaglobulinemia 9.9
265 dyskeratosis congenita 9.9
266 epidermolysis bullosa 9.9
267 tic disorder 9.9
268 newcastle disease 9.9
269 cockayne syndrome 9.9
270 testicular cancer 9.9
271 gingivitis 9.9
272 papillary carcinoma 9.9
273 thymoma 9.9
274 breast adenocarcinoma 9.9
275 kallmann syndrome 9.9
276 skin disease 9.9
277 extramedullary plasmacytoma 9.9
278 plasmacytoma 9.9
279 schneiderian carcinoma 9.9
280 pancreatic adenocarcinoma 9.9
281 spinal chordoma 9.9
282 systemic scleroderma 9.9
283 spindle cell sarcoma 9.9
284 hypokalemia 9.9
285 mucoepidermoid carcinoma 9.9
286 secretory meningioma 9.9
287 lymphoplasmacyte-rich meningioma 9.9
288 periapical granuloma 9.9
289 intestinal disease 9.9
290 anal squamous cell carcinoma 9.9
291 congestive heart failure 9.9
292 polycythemia 9.9
293 bullous pemphigoid 9.9
294 monocytic leukemia 9.9
295 soft palate cancer 9.9
296 myeloid leukemia 9.9
297 crohn's disease 9.9
298 actinic keratosis 9.9
299 psoriasis 9.9
300 skin melanoma 9.9
301 speech disorder 9.9
302 intrinsic asthma 9.9
303 alopecia 9.9
304 lymph node disease 9.9
305 heritable pulmonary arterial hypertension 9.9
306 chromosomal triplication 9.9
307 erythrokeratoderma ''en cocardes'' 9.9
308 homologous wasting disease 9.9
309 mast cell activation syndrome 9.9
310 splenomegaly 9.9
311 pituitary tumors 9.9
312 tremor 9.9
313 glial tumor 9.9
314 cerebrofacial arteriovenous metameric syndrome 9.9
315 specific language disorder 9.9
316 osteonecrosis of the jaw 9.9
317 premature aging 9.9
318 rare tumor 9.9
319 thyroid carcinoma 9.9

Graphical network of the top 20 diseases related to Oral Squamous Cell Carcinoma:



Diseases related to Oral Squamous Cell Carcinoma

Symptoms & Phenotypes for Oral Squamous Cell Carcinoma

Drugs & Therapeutics for Oral Squamous Cell Carcinoma

Drugs for Oral Squamous Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 68, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Melatonin Approved, Nutraceutical, Vet_approved Phase 3 73-31-4 896
2 Antioxidants Phase 3
3 Protective Agents Phase 3
4
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
5
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
6
Fluorouracil Approved Phase 2 51-21-8 3385
7
Cisplatin Approved Phase 1, Phase 2 15663-27-1 2767 441203 84093
8
Olaparib Approved Phase 1, Phase 2 763113-22-0 23725625
9
Morphine Approved, Investigational Phase 1, Phase 2 57-27-2 5288826
10
Dasatinib Approved, Investigational Phase 1, Phase 2 302962-49-8 3062316
11
Celecoxib Approved, Investigational Phase 2 169590-42-5 2662
12
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
13
Calcitriol Approved, Nutraceutical Phase 1, Phase 2 32222-06-3 5280453 134070
14
Vitamin D Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 1406-16-2
15
Nimotuzumab Investigational Phase 2 828933-61-3, 780758-10-3
16 Omega 3 Fatty Acid Phase 2
17 Albumin-Bound Paclitaxel Phase 2
18 Micronutrients Phase 1, Phase 2
19 Vitamins Phase 1, Phase 2
20 Trace Elements Phase 1, Phase 2
21 Hormones Phase 1, Phase 2
22 Vasoconstrictor Agents Phase 1, Phase 2
23 Dihydroxycholecalciferols Phase 1, Phase 2
24 Nutrients Phase 1, Phase 2
25 Calcium, Dietary Phase 1, Phase 2
26 Calciferol Phase 1, Phase 2
27 Immunoglobulins Phase 1, Phase 2
28 Antibodies Phase 1, Phase 2
29 Antibodies, Monoclonal Phase 1, Phase 2
30 Immunologic Factors Phase 2
31 Pharmaceutical Solutions Phase 1, Phase 2
32 Poly(ADP-ribose) Polymerase Inhibitors Phase 1, Phase 2
33 Immunosuppressive Agents Phase 2
34 Antimetabolites Phase 2
35 Insulin, Globin Zinc Phase 1, Phase 2
36 insulin Phase 1, Phase 2
37 Analgesics, Non-Narcotic Phase 2
38 Cyclooxygenase 2 Inhibitors Phase 2
39 Analgesics Phase 2
40 Cyclooxygenase Inhibitors Phase 2
41 Anti-Inflammatory Agents Phase 2
42 Antirheumatic Agents Phase 2
43 Anti-Inflammatory Agents, Non-Steroidal Phase 2
44 Protein Kinase Inhibitors Phase 2
45 Mitogens Phase 2
46
Erlotinib Hydrochloride Phase 2 183319-69-9 176871
47 Tubulin Modulators Phase 2
48 Antimitotic Agents Phase 2
49 Antineoplastic Agents, Immunological Phase 2
50
Arginine Investigational, Nutraceutical Phase 2 74-79-3 6322
51
Calcium Nutraceutical Phase 1, Phase 2 7440-70-2 271
52
Apatinib Phase 1 811803-05-1
53
carbamide peroxide Approved 124-43-6
54
Phenol Approved, Experimental Early Phase 1 108-95-2 996
55
Licorice Approved Early Phase 1
56
Ethanol Approved 64-17-5 702
57
Pancrelipase Approved, Investigational 53608-75-6
58
Cetuximab Approved 205923-56-4 56842117 2333
59
nivolumab Approved 946414-94-4
60 Raspberry Approved
61 Anti-Bacterial Agents Early Phase 1
62 Antiviral Agents Early Phase 1
63 Antimalarials Early Phase 1
64 Lugol's solution
65 Tolonium Chloride
66 pancreatin
67 Complement System Proteins
68 Anti-Infective Agents

Interventional clinical trials:

(showing 68, show less)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Adjuvant Radiotherapy in Patients With Oropharyngeal and Floor of Mouth Squamous Cell Carcinoma and Concomitant Histological Verification of Singular Ipsilateral Cervical Lymph Node Metastasis (pN1-state) Unknown status NCT00964977 Phase 3
2 Canadian Optically Guided Approach for Oral Lesions Surgical Trial - COOLS Unknown status NCT01039298 Phase 3
3 Study of TPF (Docetaxel, Cisplatin, 5-fluorouracil) Induction Chemotherapy Followed by Surgery and Radiotherapy in Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma Completed NCT01542931 Phase 2, Phase 3 TPF induction chemotherapy
4 Effect of Melatonin in Combination With Neoadjuvant Chemotherapy to HIF-1⍺, CD44, CD133, and miR-210 Expression and Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma (OSCC) Completed NCT04137627 Phase 3 Melatonin 20 MG Oral Capsule;Placebo oral capsule
5 Development of Novel Diagnostic Tools and Therapeutic Strategies for Oral Cancer Unknown status NCT02739204 Phase 2 Celecoxib
6 Randomized Placebo- Controlled Pilot Study of ZD6474 as a Chemopreventive Agent for Premalignant Lesions of the Head and Neck Unknown status NCT01414426 Phase 2 vandetanib
7 A Double Blind, Randomised, Placebo Controlled, Feasibility Phase III Clinical Trial of Peri-operative Immune-enhancing Feed in Patients Undergoing Surgery for Advanced Head and Neck Cancer Completed NCT01314755 Phase 2
8 A Phase II Study of Neoadjuvant Bio-chemotherapy With Cetuximab, Paclitaxel, and Cisplatin (CPC) Followed by Cetuximab-based Concurrent Bio-radiotherapy in High-risk Locally Advanced Oral Squamous Cell Carcinoma (OSCC) Completed NCT00933387 Phase 2 Cetuximab,Paclitaxel,Cisplatin
9 Treatment of Oral Lichen Planus Lesions Completed NCT00746772 Phase 2 Purslane 235mg/day in one dosage;Placebo : one dosage
10 Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity Completed NCT00953849 Phase 1, Phase 2 Celecoxib;Calcitriol;Celecoxib plus Calcitriol
11 Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention Completed NCT01192204 Phase 1, Phase 2 10% FBR containing bioadhesive gel;placebo gel
12 Phase 1/2, Open-Label, Single-Arm Safety and Efficacy Dose-Finding, Systemic Exposure, and Device Technical Effects of PRV111 (Cisplatin Transmucosal System) in Subjects With Oral Squamous Cell Carcinoma Recruiting NCT03502148 Phase 1, Phase 2 PRV111 (Cisplatin Transmucosal System)
13 A Phase I/II Study of the Fluorescent PARP1 Binding Imaging Agent PARPi-FL in Patients With Oral Squamous Cell Carcinomas Recruiting NCT03085147 Phase 1, Phase 2 Olaparib
14 Cyclin D1 Based TPF(Docetaxel, Cisplatin and 5-fluorouracil) Induction Chemotherapy for OSCC(Oral Squamous Cell Carcinoma) Patients at cN2(Clinical Node 2) Stage: a Phase II Randomized Controlled Trial Recruiting NCT02290145 Phase 2 TPF group
15 A Randomized Phase II Trial of TPF Induction Chemotherapy in cN2 Patients With Oral Squamous Cell Carcinoma Recruiting NCT02285543 Phase 2 TPF induction chemotherapy
16 GDF15 (Growth Differentiation Factor 15) Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at T3/T4cN0M0 Stage: a Phase II Randomized Controlled Trial Recruiting NCT02285530 Phase 2 TPF induction chemotherapy
17 A Randomized Phase II Trial of Low Stathmin Expression as a Predictive Biomarker for OSCC Patients Receiving TPF Induction Chemotherapy Followed by Radical Surgery and Radiotherapy/Chemoradiotherapy Recruiting NCT03326947 Phase 2 docetaxel, cisplatin and 5-fluorouracil
18 A Phase I/II Trial of the Insulin-Like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in Patients With Embryonal and Alveolar Rhabdomyosarcoma Recruiting NCT03041701 Phase 1, Phase 2 Dasatinib;Ganitumab
19 Effect of COX-2 (Cyclooxygenase-2) and EGFR (Epidermal Growth Factor Receptor) Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study. Active, not recruiting NCT02748707 Phase 2 Arm1;Arm 2;Arm 3
20 A Phase II, Prospective, Single-center, Randomized, Controlled Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma Not yet recruiting NCT04367909 Phase 2 Nimotuzumab;Docetaxel;Carboplatin
21 Free Soft Tissue Graft in Treatment of Oral Lichen Planus Unknown status NCT00737854 Phase 1
22 Phase I Trial Of Intratumoral EGFR Antisense DNA And DC-Chol Liposomes In Advanced Oral Squamous Cell Carcinoma Completed NCT00009841 Phase 1 DC-cholesterol liposome
23 Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma: A Single-arm Phase I Trial Recruiting NCT04393506 Phase 1 Camrelizumab;Apatinib
24 Safety and Efficacy Evaluation of Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (Non NPC): A Phase I Trial Recruiting NCT04413214 Phase 1 Carrimycin
25 The Role of microRNA-29b in the Oral Squamous Cell Carcinoma Unknown status NCT02009852
26 Pivotal Validation Study of Salivary Biomarkers for the Risk Stratification of Patients With Lesions Suspicious for Oral Squamous Cell Carcinoma Unknown status NCT01587573
27 Validation of Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study Unknown status NCT03345966
28 Apoptotic and Anti-Proliferative Effects of Licorice Extract (Licochalcone A) and Paclitaxel Chemotherapy on Human Oral Squamous Cell Carcinoma Cell Line Unknown status NCT03292822 Early Phase 1 Paclitaxel
29 Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma Unknown status NCT01987934
30 The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma Unknown status NCT01946230
31 SEND Trial The Role of Selective Neck Dissection Used Electively in Patients With Early Oral Squamous Cell Carcinoma (1-3cm Primary Size) and No Clinical Evidence of Lymph Node Metastases in the Neck Unknown status NCT00571883
32 Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus. Diagnostic Value of White Light Endoscopy, Narrow Band Imaging and Chromoendoscopy for Detection of Esophageal Manifestation in Patients With Oral Lichen. Unknown status NCT02532166
33 The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma Unknown status NCT00173849
34 The Relation of Microtubule-Associated Protein 2 and Cell Migration Unknown status NCT00174109
35 The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer Unknown status NCT01627119
36 A Phase 1b Pilot Study Evaluating Oral Administration of Freeze-Dried Black Raspberries in Pre-Surgical Patients With Oral Squamous Cell Carcinoma Completed NCT01465776
37 Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma Completed NCT03554967
38 Epstein-Barr Detection in Squamous Cell Carcinoma and Healthy Oral Mucosa Completed NCT01039272
39 Modern Hybrid Imaging for Staging and Monitoring Patients With Oral Squamous Cell Carcinoma Completed NCT04280159
40 Fluorescent Visualization in Early Oral Cancer Completed NCT02306967
41 Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma. (Retrospective-cohort Study) Completed NCT03109457
42 Molecular Mechanisms of Precancerous and Cancerous Lesions of the Oral Cavity Completed NCT03026361
43 Salivary and Serum Levels of Chemerin and MMP-9 in Oral Precancer and Oral Squamous Cell Carcinoma. Completed NCT02323672
44 A Cohort Study on Prediction of Malignant Transformation of Oral Epithelial Dysplasia by p16 Methylation Completed NCT00835341
45 Oral Metal Contact Allergy: A Cause of Oral Squamous Cell Carcinoma? Completed NCT00693550
46 Detection of Salivary 8-Hydroxy-2-Deoxyguanosine and Total Antioxidant Capacity in Patients With Oral Premalignant and Malignant Lesions Completed NCT03830710
47 Interest of Oral Tissue Autofluorescence for the Screening of Precancerous Lesions and Cancer in Population With Tobacco and Alcohol Abuse. Completed NCT01167790
48 Assessing Efficacy of Neoadjuvant Chemoradiotherapy as a Treatment Plan for Patients With Stage IVa Oral Cancer. Completed NCT03923998 Early Phase 1 Neoadjuvant chemotherapy
49 Comparison of Detection of Human Papillomavirus on Tissue, Saliva and Serum Completed NCT01043328
50 Real-time Semi-quantification of Endoscopic Ultrasound Elastography and Contrast-enhancement Using Strain Histograms (SH) and Contrast-enhancement (CE) for the Differentiation of Focal Pancreatic Masses and the Assessment of Lymph Node Involvement Completed NCT02459041
51 A Randomized,Multicenter,Prospectie,Controlled Clinical Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma. Recruiting NCT02743832
52 Submandibular Gland Preservation During Neck Dissection for Oral Squamous Cell Carcinoma Recruiting NCT03385720
53 Survival Benefit of Elective Neck Dissection for Patients With T1,2N0M0 Oral Squamous Cell Carcinoma—A Prospective Multicenter Randomized Controlled Study Recruiting NCT01334320
54 Multispectral Optoacoustic Imaging Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases: a Single Center Proof of Concept Study Recruiting NCT03923881
55 Analysis of the Variation in Caspase-8 Availability and Cleavage in Oral Squamous Cell Carcinoma Recruiting NCT03877159
56 The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw Recruiting NCT03418454
57 The Role of the Central Memory Phenotype in Predicting Response to PD-1 Inhibition in Pre-clinical Models of Oral Cancer Recruiting NCT03862066
58 Adjuvant Radiotherapy in Early Stage Oral Cancers (AREST) Recruiting NCT03853655
59 Prospective Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore Recruiting NCT03975322
60 Myeloid-derived Suppressor Cells (MDSCs) Detection Before and After Beta-glucan Administration in Oral Squamous Cell Carcinoma Patients Active, not recruiting NCT04387682
61 A Randomized, Double Blind, Controlled, Multi-center, Phase III Study to Assess Efficacy of Low Level Diode Laser (100 MW, 658 Nm), in the Prevention and Treatment of Radiochemotherapy-induced Mucositis in Head and Neck Cancer. Active, not recruiting NCT01772706
62 Using MASL to Combat Oral Cancer Not yet recruiting NCT04188665 Early Phase 1 MASL
63 Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population Not yet recruiting NCT04270201
64 Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line Not yet recruiting NCT03619304
65 International, Multicenter, Prospective Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction (SMDR) Following Oral Squamous Cell Carcinoma (OSSC) Resection Not yet recruiting NCT04098146
66 Effect of Oral Black Raspberry Administration on Oral Cell DNA Adducts in Smokers Not yet recruiting NCT04372914
67 Feasibility of Holmium-166 Microspheres for Selective Intra-tumoural Treatment in Head and Neck Cancer: Biodistribution and Safety in Patients With Malignancy of the Tongue Terminated NCT02975739
68 Molecular Mechanisms of OSCC Tumor Invasion Withdrawn NCT00899704

Search NIH Clinical Center for Oral Squamous Cell Carcinoma

Genetic Tests for Oral Squamous Cell Carcinoma

Anatomical Context for Oral Squamous Cell Carcinoma

MalaCards organs/tissues related to Oral Squamous Cell Carcinoma:

40
Lymph Node, Tongue, Bone, Endothelial, T Cells, Neutrophil, Skin

Publications for Oral Squamous Cell Carcinoma

Articles related to Oral Squamous Cell Carcinoma:

(showing 9524, show less)
# Title Authors PMID Year
1
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. 46 61
19396866 2009
2
The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. 46 61
19435529 2009
3
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. 61 46
18381414 2008
4
Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. 46
18946016 2008
5
Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis. 61
32466707 2020
6
R2TP/PAQosome as a promising chemotherapeutic target in cancer. 61
31890057 2020
7
MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. 61
31906769 2020
8
CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway. 61
32017846 2020
9
Anti-fungal drug itraconazole exerts anti-cancer effects in oral squamous cell carcinoma via suppressing Hedgehog pathway. 61
32407849 2020
10
Modulating effect of Coronarin D in 5-fluorouracil resistance human oral cancer cell lines induced apoptosis and cell cycle arrest through JNK1/2 signaling pathway. 61
32502840 2020
11
Human Papillomavirus E6/E7 mRNA detection by in situ hybridization in oral cavity squamous cell carcinoma. 61
32464412 2020
12
MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma. 61
32445972 2020
13
Light stimulus responsive nanomedicine in the treatment of oral squamous cell carcinoma. 61
32402938 2020
14
Automated classification of cells into multiple classes in epithelial tissue of oral squamous cell carcinoma using transfer learning and convolutional neural network. 61
32416467 2020
15
Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach. 61
31748878 2020
16
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis. 61
32330687 2020
17
A Phase 2 Trial of Chemoradiation Therapy Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients. 61
32126267 2020
18
Identification, characterization and microRNA expression profiling of side population cells in human oral squamous cell carcinoma Tca8113 cell lines. 61
32319646 2020
19
Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells. 61
31937145 2020
20
Rac1-dependent phagocytosis of apoptotic cells by oral squamous cell carcinoma cells: A possible driving force for tumor progression. 61
32320683 2020
21
Repertoire of peripheral T cells in patients with oral squamous cell carcinoma. 61
32097519 2020
22
Predictive value of prognostic nutritional index in patients with oral squamous cell carcinoma. 61
32125746 2020
23
SATB2 knockdown decreases hypoxia-induced autophagy and stemness in oral squamous cell carcinoma. 61
32566006 2020
24
Identification and validation of seven prognostic long non-coding RNAs in oral squamous cell carcinoma. 61
32566023 2020
25
Identification of Differentially Expressed Proteins from Smokeless Tobacco Addicted Patients Suffering from Oral Squamous Cell Carcinoma. 61
31446608 2020
26
Focal Adhesion Kinase (FAK) Overexpression and Phosphorylation in Oral Squamous Cell Carcinoma and their Clinicopathological Significance. 61
31522363 2020
27
Periodontitis and oral Cancer-A striking link. 61
32147310 2020
28
Oral cancer in a 5-year-old boy: a rare case report and review of literature. 61
32312529 2020
29
Porphyromonas gingivalis Promotes Immunoevasion of Oral Cancer by Protecting Cancer from Macrophage Attack. 61
32471882 2020
30
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis. 61
31489575 2020
31
The role of long non-coding RNA CASC2 in the carcinogenesis process. 61
32559846 2020
32
Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma. 61
31471883 2020
33
TGF-β1 induces N-cadherin expression by upregulating Sox9 expression and promoting its nuclear translocation in human oral squamous cell carcinoma cells. 61
32565972 2020
34
Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma. 61
32450050 2020
35
Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma. 61
32377747 2020
36
Assessment of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Prognosis of Oral Squamous Cell Carcinoma. 61
32027861 2020
37
Characterisation of a subpopulation of CD133+ cancer stem cells from Chinese patients with oral squamous cell carcinoma. 61
32483269 2020
38
Correction to: Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. 61
31853006 2020
39
BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene. 61
32499570 2020
40
Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma. 61
32103293 2020
41
Prognostic ability of DNA-binding protein inhibitor ID-1 expression in patients with oral squamous cell carcinoma. 61
32382338 2020
42
Elective neck dissection versus observation for early-stage oral squamous cell carcinoma: Systematic review and meta-analysis. 61
32244173 2020
43
Specific Deletion of p16INK4a with Retention of p19ARF Enhances the Development of Invasive Oral Squamous Cell Carcinoma. 61
32194051 2020
44
Expression of Concern: MUC1 gene silencing inhibits proliferation, invasion and migration while promoting apoptosis of oral squamous cell carcinoma cells. 61
32579205 2020
45
CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway. 61
32572877 2020
46
LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study. 61
32088612 2020
47
Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study. 61
32546692 2020
48
METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification. 61
32145676 2020
49
Mass Spectrometry-Based Lipidomics of Oral Squamous Cell Carcinoma Tissue Reveals Aberrant Cholesterol and Glycerophospholipid Metabolism - A Pilot Study. 61
32559714 2020
50
Prognostic value of log odds of positive lymph nodes in patients with resectable oral squamous cell carcinoma. 61
32535340 2020
51
Elevated expression of protease-activated receptor 1 via ΔNp63 down-regulation contributes to nodal metastasis in oral squamous cell carcinoma. 61
32536459 2020
52
Pichia fermentans originates apoptosis in human oral squamous cell carcinoma by over-expressing BAX and CASP 9 genes. 61
32253629 2020
53
Campaign to Increase Awareness of Oral Cancer Risk Factors Among Preadolescents. 61
30835060 2020
54
M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT. 61
32526707 2020
55
Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies. 61
32519370 2020
56
Second primary tumors in proliferative verrucous leukoplakia: a series of 33 cases. 61
31440840 2020
57
Marked epithelial to mesenchymal transition in surgical margins of oral cancer-an in vitro study. 61
32382327 2020
58
Endothelial nitric oxide synthase polymorphisms/haplotypes are strong modulators of oral cancer risk in Serbian population. 61
32493866 2020
59
Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4. 61
32472755 2020
60
CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma. 61
32529269 2020
61
Development of DNA polymer films as a drug delivery system for the treatment of oral cancer. 61
32572698 2020
62
Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients. 61
32568174 2020
63
Salivary β2-microglobulin levels in patients with erosive oral lichen planus and squamous cell carcinoma. 61
32552881 2020
64
Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone. 61
32575541 2020
65
Polarization gating technique extracts depth resolved fluorescence redox ratio in oral cancer diagnostics. 61
32335189 2020
66
Histone deacetylase 1 regulates the malignancy of oral cancer cells via miR-154-5p/PCNA axis. 61
32549181 2020
67
Sarcomatoid variant of squamous carcinoma in recurrent and second primary tumors of the oral cavity. 61
32506553 2020
68
Long Noncoding RNA RC3H2 Facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC. 61
32163895 2020
69
The potentialities of the Anatomage Table for head and neck pathology: medical education and informed consent. 61
31828453 2020
70
MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma. 61
31857683 2020
71
Difference between Female and Male Patients with Oral Squamous Cell Carcinoma: A Single-Center Retrospective Study in Taiwan. 61
32512723 2020
72
Coexisting overexpression of STOML1 and STOML2 proteins may be associated with pathology of oral squamous cell carcinoma. 61
32402568 2020
73
Mandible handling in the surgical treatment of oral squamous cell carcinoma: lessons from clinical results after marginal and segmental mandibulectomy. 61
32102765 2020
74
Histological Features and Survival in Young Patients with HPV Negative Oral Squamous Cell Carcinoma. 61
32531817 2020
75
Perineural Invasion in Oral Squamous cell Carcinoma: Incidence, prognostic Impact and Molecular Insight. 61
32533593 2020
76
Identification of an Immune Score-Based Gene Panel with Prognostic Power for Oral Squamous Cell Carcinoma. 61
32529991 2020
77
Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells. 61
32546118 2020
78
Salvage surgery with second free flap reconstruction for recurrent oral squamous cell carcinoma. 61
32566774 2020
79
Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma. 61
32569675 2020
80
β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. 61
32203567 2020
81
Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a. 61
32406610 2020
82
Hsa_circRNA_101036 acts as tumor-suppressor in oral squamous cell carcinoma cells via inducing endoplasmic reticulum stress. 61
32572876 2020
83
Hedgehog Signaling Promotes Multidrug Resistance by Regulation of ABC Transporters in Oral Squamous Cell Carcinoma. 61
32512620 2020
84
Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma. 61
32162011 2020
85
Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma. 61
32495292 2020
86
Clinical significance of the G8 screening tool in elderly patients with oral squamous cell carcinoma. 61
31410674 2020
87
SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma. 61
32506729 2020
88
The antilymphatic metastatic effect of hyaluronic acid in a mouse model of oral squamous cell carcinoma. 61
32186431 2020
89
Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1. 61
32346435 2020
90
The identification of autophagy-related genes in the prognosis of oral squamous cell carcinoma. 61
32558072 2020
91
Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients. 61
32577165 2020
92
JunB can enhance the transcription of IL-8 in oral squamous cell carcinoma. 61
32510596 2020
93
Immunohistochemical Investigation of Predictive Biomarkers for Mandibular Bone Invasion in Oral Squamous Cell Carcinoma. 61
32524367 2020
94
An Unusual Histopathological Presentation of Epidermotropic Metastatic Pharyngeal Squamous Cell Carcinoma. 61
32568841 2020
95
Loss of NF-kB1 and c-Rel accelerates oral carcinogenesis in mice. 61
32568418 2020
96
Dual spinal accessory nerve: caution during neck dissection. 61
32565439 2020
97
Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study. 61
32552873 2020
98
Are Histomorphological Features Predictive of p16 Immunopositivity Different for Oral and Oropharyngeal Squamous Cell Carcinoma? 61
32523271 2020
99
Chemopreventive effect of modified zengshengping on oral cancer in a hamster model and assessment of its effect on liver. 61
32198081 2020
100
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. 61
31896811 2020
101
MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression. 61
32568182 2020
102
Trends and clinicopathological characteristics of oral squamous cell carcinomas reported at a tertiary cancer hospital in Nepal during 1999 to 2009. 61
32488959 2020
103
Curcumin inhibits epithelial-mesenchymal transition in oral cancer cells via c-Met blockade. 61
32391111 2020
104
Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro. 61
32495222 2020
105
Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression. 61
32493454 2020
106
PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. 61
32152233 2020
107
From Beyond the Pale to the Pale Riders: The Emerging Association of Bacteria with Oral Cancer. 61
32091956 2020
108
Hypoallergenic infant formula lacks transforming growth factor beta activity and has a lower anti-inflammatory activity than regular infant formula. 61
32505409 2020
109
Genomic Signature of Mismatch Repair Deficiency in Areca Nut-Related Oral Cancer. 61
32527169 2020
110
Adipocyte-tumor cell native encounter in oral squamous cell carcinoma. 61
32539566 2020
111
Editorial: Postoperative risk stratification in oral squamous cell carcinoma. 61
31987683 2020
112
Pericyte in Oral Squamous Cell Carcinoma: A Systematic Review. 61
32506378 2020
113
Oral squamous cell carcinoma around dental implant mimicking peri-implantitis. 61
32386923 2020
114
Diagnostic accuracy of brush biopsy-based cytology for the early detection of oral cancer and precursors in Fanconi anemia. 61
32022466 2020
115
Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression in an Immune Microenvironment. 61
32298192 2020
116
Efficacy and toxicity of prolonged pegylated liposomal doxorubicin use in women with recurrent epithelial ovarian cancer. 61
32499072 2020
117
Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis. 61
32344357 2020
118
Automatic detection of cervical lymph nodes in patients with oral squamous cell carcinoma using a deep learning technique: a preliminary study. 61
32506212 2020
119
Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: a preliminary study. 61
32506786 2020
120
Corrigendum for "Focal Adhesion Kinase knockdown in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis via Downregulating MCP-1/CCL2 Expression" (Vol. 29, Issue 2). 61
32462755 2020
121
Locoregional recurrence rate and disease-specific survival following marginal vs segmental resection for oral squamous cell carcinoma with mandibular bone invasion. 61
32516499 2020
122
Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis. 61
32100133 2020
123
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients. 61
32538743 2020
124
Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis. 61
32548858 2020
125
Practical Challenges in Measurement of Depth of Invasion in Oral Squamous Cell Carcinoma: Pictographical Documentation to Improve Consistency of Reporting per the AJCC 8th Edition Recommendations. 61
31230230 2020
126
Molecular mechanism of action of new 1,4-naphthoquinones tethered to 1,2,3-1H-triazoles with cytotoxic and selective effect against oral squamous cell carcinoma. 61
32554278 2020
127
High-risk human papillomavirus in patients with oral leukoplakia and oral squamous cell carcinoma - A multi-centre study in Sweden, Brazil and Romania. 61
32568421 2020
128
Expression of MMR system genes is correlated to NF-kB in patients with oral squamous cell carcinoma. 61
31662440 2020
129
Noncalcemic Vitamin D Hydroxyderivatives Inhibit Human Oral Squamous Cell Carcinoma and Down-regulate Hedgehog and WNT/β-Catenin Pathways. 61
32366390 2020
130
Evaluation of synuclein-γ levels by novel monoclonal antibody in saliva and cancer tissues from oral squamous cell carcinoma patients. 61
32202903 2020
131
MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway. 61
32064884 2020
132
Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1. 61
32122140 2020
133
Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma. 61
32130788 2020
134
Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma. 61
32037955 2020
135
MiR-34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2. 61
31663131 2020
136
Dynamic evaluation of conditional survival in patients with oral squamous cell carcinoma after surgical resection: A large-scale prospective study. 61
32220811 2020
137
Identification of cancer hallmark-associated gene and lncRNA cooperative regulation pairs and dictate lncRNA roles in oral squamous cell carcinoma. 61
32202050 2020
138
Anticancer properties of the fatty acid synthase inhibitor TVB-3166 on oral squamous cell carcinoma cell lines. 61
32197133 2020
139
Detection of oral squamous cell carcinoma with ex vivo fluorescence confocal microscopy: sensitivity and specificity compared to histopathology. 61
32418329 2020
140
Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2. 61
32410389 2020
141
LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis. 61
32495922 2020
142
Hypermethylated PAX1 and ZNF582 genes in the tissue sample are associated with aggressive progression of oral squamous cell carcinoma. 61
32428271 2020
143
Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma. 61
32400862 2020
144
Does SPECT Provide Incremental Value to CT or MRI in Assessing Mandibular Invasion by Oral Squamous Cell Carcinoma? 61
32001199 2020
145
Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway. 61
32086839 2020
146
MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway. 61
32432743 2020
147
Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders. 61
32378537 2020
148
DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications. 61
32433822 2020
149
Oral cancer-associated fibroblasts predict poor survival: Systematic review and meta-analysis. 61
31179584 2020
150
The stress hormone norepinephrine promotes tumor progression through β2-adrenoreceptors in oral cancer. 61
32234582 2020
151
The prognostic significance of the lymph node ratio in oral cancer differs for anatomical subsites. 61
31740138 2020
152
Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials. 61
32384682 2020
153
An integrated approach for preventing oral cavity and oropharyngeal cancers: two etiologies with distinct and shared mechanisms of carcinogenesis. 61
32434808 2020
154
Nothing to sneeze at: Histamine and histamine receptors in oral carcinogenesis. 61
32395857 2020
155
MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells. 61
32378714 2020
156
Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis. 61
32371264 2020
157
The current markers of cancer stem cell in oral cancers. 61
32135187 2020
158
A critical evaluation of computed tomography-derived depth of invasion in the preoperative assessment of oral cancer staging. 61
32388410 2020
159
Expressions of extracellular matrix-remodeling factors in lymph nodes from oral cancer patients. 61
32419185 2020
160
Helicobacter pylori was not detected in oral squamous cell carcinomas from cohorts of Norwegian and Nepalese patients. 61
32457404 2020
161
Health-related quality of life after oral cancer treatment: 10-year outcomes. 61
32493685 2020
162
Pineal gland protects against chemically induced oral carcinogenesis and inhibits tumor progression in rats. 61
32499868 2020
163
Clinicopathological and prognostic characterization of oral lichenoid disease and its main subtypes: A series of 384 cases. 61
32388519 2020
164
Historical Vignette: Attempted treatment of Sigmund Freud's oral squamous cell carcinoma by vasectomy (Steinach Operation) in 1923. 61
31705580 2020
165
Surgical sequence of neck dissection and primary tumor excision could impact the locoregional recurrence rates in oral squamous cell carcinoma. 61
32448740 2020
166
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma. 61
32388408 2020
167
Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma. 61
32445747 2020
168
Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma. 61
32450006 2020
169
Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders. 61
31056829 2020
170
Chemopreventive activity of Tualang honey against oral squamous cell carcinoma-in vivo. 61
32173393 2020
171
Biological behavior of oral squamous cell carcinoma in the background of novel corona virus infection. 61
32402653 2020
172
CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity. 61
31603606 2020
173
Why SLNB procedure is not currently used in early stage oral squamous cell carcinoma? 61
32402657 2020
174
Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis. 61
32424132 2020
175
CCL18 overexpression predicts a worse prognosis in oral squamous cell carcinoma (OSCC). 61
32202908 2020
176
Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. 61
32398775 2020
177
Identification of hub methylated-CpG sites and associated genes in oral squamous cell carcinoma. 61
32155325 2020
178
Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population. 61
32458634 2020
179
CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2. 61
32495877 2020
180
Treatment of facial myiasis in an elderly patient with oral squamous cell carcinoma: Case report. 61
32492640 2020
181
Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma. 61
32458620 2020
182
Identification of Novel Candidate Biomarkers for Oral Squamous Cell Carcinoma Based on Whole Gene Expression Profiling. 61
32468250 2020
183
Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding. 61
31984527 2020
184
MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma. 61
32086979 2020
185
Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma. 61
32167621 2020
186
The impact of preoperative glycated hemoglobin levels on outcomes in oral squamous cell carcinoma. 61
32426892 2020
187
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. 61
31637730 2020
188
Aberrant Expression of miR-103, miR-184, miR-378, miR-497 and miR-506 in Tumor Tissue from Patients with Oral Squamous Cell Carcinoma Regulates the Clinical Picture of the Patients. 61
32458638 2020
189
Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma. 61
32437034 2020
190
Tumor-derived exosomes in the regulation of macrophage polarization. 61
32162012 2020
191
Sarcopenia results in poor survival rates in oral cavity cancer patients. 61
31769607 2020
192
Micro-metastasis and isolated tumour cells: the span between elective neck dissection versus neck observation in early oral cancer. 61
32468427 2020
193
High-risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer. 61
32449223 2020
194
Epigallocatechin-3-gallate sensitises multidrug-resistant oral carcinoma xenografts to vincristine sulphate. 61
32475087 2020
195
A Machine-learning Approach for the Assessment of the Proliferative Compartment of Solid Tumors on Hematoxylin-Eosin-Stained Sections. 61
32466184 2020
196
Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia. 61
32481659 2020
197
Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC. 61
32414418 2020
198
Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. 61
32499869 2020
199
Usefulness of Sentinel Lymph Node Biopsy for Oral Cancer: A Systematic Review and Meta-Analysis. 61
32401367 2020
200
Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study. 61
32132387 2020
201
ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells. 61
32162845 2020
202
Impact of dietary vitamin D on initiation and progression of oral cancer. 61
31981799 2020
203
TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation. 61
32385953 2020
204
NOVEL USE OF FLUORESCEIN DYE IN DETECTION OF ORAL DYSPLASIA AND ORAL CANCER. 61
32450303 2020
205
Oral squamous cell carcinoma of the tongue dorsum with multiple cancer-associated mutations in the TP53 gene. 61
32451170 2020
206
Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining. 61
32451767 2020
207
Survival outcomes after surgical treatment of oral squamous cell carcinoma. 61
32428375 2020
208
iRhom2 in the pathogenesis of oral squamous cell carcinoma. 61
32236893 2020
209
Staging and grading of oral squamous cell carcinoma: An update. 61
32446214 2020
210
Expression of HER-2/neu in Oral Squamous Cell Carcinoma. 61
32458657 2020
211
Postoperative risk stratification in oral squamous cell carcinoma. 61
32222310 2020
212
Relevance and actionable mutational spectrum in oral squamous cell carcinoma. 61
31845386 2020
213
Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma. 61
32455867 2020
214
Clinical validity and conceptual interpretation of systematic review and meta-analysis on elective neck dissection (END) versus observation for early-stage oral squamous cell carcinoma (OSCC). 61
32402654 2020
215
Scapular free flap as a good choice for mandibular reconstruction: 119 out of 280 cases after resection of oral squamous cell carcinoma in a single institution. 61
32201048 2020
216
Mucoadhesive emulgel systems containing curcumin for oral squamous cell carcinoma treatment: From pre-formulation to cytotoxicity in tissue-engineering oral mucosa. 61
32450222 2020
217
Diagnostic value of 18F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8+tumour-infiltrating lymphocytes in oral squamous cell carcinoma. 61
32238919 2020
218
Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma. 61
32319583 2020
219
The potential influence of long non-coding RNA PRKG1-AS1 on oral squamous cell carcinoma: A comprehensive study based on bioinformatics and in vitro validation. 61
31788859 2020
220
Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population. 61
32509227 2020
221
Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma. 61
32410646 2020
222
Predictive value of genetic variants XRCC1 rs1799782, APEX1 rs1760944, and MUTYH rs3219489 for adjuvant concurrent chemoradiotherapy outcomes in oral squamous cell carcinoma patients. 61
32461665 2020
223
Correction: Stalder, et al.; Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. Biology 2020, 9, 23. 61
32485844 2020
224
Evaluation of non-Gaussian model-based diffusion-weighted imaging in oral squamous cell carcinoma: comparison with tumour functional information derived from positron-emission tomography. 61
31987487 2020
225
MED15, transforming growth factor beta 1 (TGF-β1), FcγRIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. 61
32439976 2020
226
Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma. 61
32339995 2020
227
p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling. 61
32356317 2020
228
[Corrigendum] Novel polygodial analogs P3 and P27: Efficacious therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma. 61
32319547 2020
229
LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2. 61
31995261 2020
230
Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma. 61
32012401 2020
231
Multi-Region Sequence Analysis of a Pregnancy-Related Oral Squamous Cell Carcinoma Exhibiting Low-Level Aggressive Behavior. 61
31544567 2020
232
Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma. 61
32114253 2020
233
IκB kinase α: an independent prognostic factor that promotes the migration and invasion of oral squamous cell carcinoma. 61
31859105 2020
234
MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway. 61
32329848 2020
235
mRNA and P-element-induced wimpy testis-interacting RNA profile in chemical-induced oral squamous cell carcinoma mice model. 61
31748426 2020
236
Oral sarcomatoid squamous cell carcinoma: a retrospective study based on 14 cases. 61
31642511 2020
237
GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression. 61
32325008 2020
238
Association of oral dysbiosis with oral cancer development. 61
32211076 2020
239
A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. 61
32218834 2020
240
Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. 61
32348606 2020
241
Histopathological imaging database for oral cancer analysis. 61
32021884 2020
242
Foxp3+ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs. 61
32347186 2020
243
Mast Cells and Blood Vessels Profile in Oral Carcinogenesis: An Immunohistochemistry Study. 61
32334476 2020
244
Identification of oral cancer in OCT images based on an optical attenuation model. 61
32335743 2020
245
MiR-210-3p-EphrinA3-PI3K/AKT axis regulates the progression of oral cancer. 61
32180353 2020
246
Squamous cell carcinoma of the oral tongue: Distinct epidemiological profile disease. 61
32320105 2020
247
Epigenetic Alterations Associated with the Overall Survival and Recurrence Free Survival among Oral Squamous Cell Carcinoma Patients. 61
32272578 2020
248
Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC). 61
31197568 2020
249
Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention. 61
32246747 2020
250
hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p. 61
32302508 2020
251
MiR-802 inhibits the malignant biological behavior of oral squamous cell carcinoma by targeting proto-oncogene MET. 61
32373961 2020
252
Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins. 61
31897720 2020
253
CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells. 61
31889370 2020
254
Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions. 61
31654153 2020
255
Downregulation of MicroRNA 551b Correlates With Dissemination of Human Oral Squamous Cell Carcinoma. 61
32376241 2020
256
Cervical Lymph Node Metastases in Oral Squamous Cell Carcinoma-How Much Imaging Do We Need? 61
32252409 2020
257
Immunological and Clinicopathological Significance of MFG-E8 Expression in Patients with Oral Squamous Cell Carcinoma. 61
31256324 2020
258
HIKESHI silencing can enhance mild hyperthermia sensitivity in human oral squamous cell carcinoma HSC‑3 cells. 61
32377716 2020
259
MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene. 61
30949866 2020
260
Identification of a novel fusion gene, TRIM52-RACK1, in oral squamous cell carcinoma. 61
32251686 2020
261
Time to revisit the tumor margins in post NACT oral squamous cell carcinoma. 61
32265104 2020
262
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma. 61
32218858 2020
263
Automated oral squamous cell carcinoma identification using shape, texture and color features of whole image strips. 61
32223950 2020
264
Salicylate sensitizes oral squamous cell carcinoma to chemotherapy through targeting mTOR pathway. 61
32267053 2020
265
Oral squamous cell carcinoma: epidemiological study and risk factor assessment based on a 39-year series. 61
32360101 2020
266
Sulphur-doped carbon dots as a highly efficient nano-photodynamic agent against oral squamous cell carcinoma. 61
32301195 2020
267
MiR-503-5p functions as an oncogene in oral squamous cell carcinoma by targeting Smad7. 61
32319077 2020
268
Treatment strategies for and outcomes of older patients with oral squamous cell carcinoma. 61
32102767 2020
269
Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma. 61
31468114 2020
270
miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2. 61
32170966 2020
271
Glutathione-sensitive and folate-targeted nanoparticles loaded with paclitaxel to enhance oral squamous cell carcinoma therapy. 61
32207763 2020
272
KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma. 61
32181476 2020
273
Milk lactoperoxidase decreases ID1 and ID3 expression in human oral squamous cell carcinoma cell lines. 61
32246075 2020
274
Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma. 61
32250571 2020
275
Expression and prognostic significance of the P53-related DNA damage repair proteins checkpoint kinase 1 (CHK1) and growth arrest and DNA-damage-inducible 45 alpha (GADD45A) in human oral squamous cell carcinoma. 61
32154612 2020
276
Optical fluorescence imaging in oral cancer and potentially malignant disorders: A systematic review. 61
30810255 2020
277
An update of knowledge on PD-L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives. 61
30866171 2020
278
Evaluation and Expression of Survivin in Potentially Malignant Lesions and Squamous Cell Carcinoma: A Comparative Study. 61
32382455 2020
279
Anticancer effects induced by artichoke extract in oral squamous carcinoma cell lines. 61
32372389 2020
280
MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer. 61
32238162 2020
281
Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer. 61
32441651 2020
282
Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling. 61
32319563 2020
283
Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer. 61
32279466 2020
284
MicroRNA-378-3p/5p represses proliferation and induces apoptosis of oral squamous carcinoma cells via targeting KLK4. 61
31868942 2020
285
[Study on expression of LIM domain only protein 1 in SD rat oral buccal mucosa carcinogenesis induced by 4-nitro-quinoline N-oxide]. 61
32314884 2020
286
Black Raspberry Inhibits Oral Tumors in Mice Treated with the Tobacco Smoke Constituent Dibenzo(def,p)chrysene Via Genetic and Epigenetic Alterations. 61
31969344 2020
287
MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression. 61
31265790 2020
288
Can Sentinel Lymph Node Biopsy Predict Various Levels of Echelon Nodes in Oral Cancers? 61
32256831 2020
289
Perspective on muscle-tumor interaction in oral squamous cell carcinoma. 61
32273154 2020
290
Calcified keratin pearls in oral squamous cell carcinoma. 61
32276815 2020
291
Translational genomics and recent advances in oral squamous cell carcinoma. 61
31542510 2020
292
Financial burden of oral squamous cell carcinoma in India. 61
31866219 2020
293
Anti-PD-L1-modified and ATRA-loaded nanoparticles for immuno-treatment of oral dysplasia and oral squamous cell carcinoma. 61
32255397 2020
294
MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR. 61
32202300 2020
295
Oral submucous fibrosis in Asian countries. 61
31310693 2020
296
Quadruple Multiple Primary Malignancies: Early Detection of Second Primary Malignancy by Esophagogastroduodenoscopy/Colonoscopy Is Crucial for Patients with Classic Kaposi's Sarcoma. 61
32295165 2020
297
Diminished CD68+ Cancer-Associated Fibroblast Subset Induces Regulatory T-Cell (Treg) Infiltration and Predicts Poor Prognosis of Oral Squamous Cell Carcinoma Patients. 61
32035062 2020
298
Stathmin guides personalized therapy in oral squamous cell carcinoma. 61
31994271 2020
299
Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7-H5 and their relationship with cancer prognosis. 61
31901178 2020
300
CT evaluation of extranodal extension of cervical lymph node metastases in patients with oral squamous cell carcinoma using deep learning classification. 61
31197738 2020
301
RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma. 61
31997535 2020
302
The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma. 61
32341586 2020
303
FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma. 61
32329846 2020
304
Cytotoxic Effects of Betel Quid and Areca Nut Aqueous Extracts on Mouse Fibroblast, Human Mouth-Ordinary-Epithelium 1 and Human Oral Squamous Cell Carcinoma Cell Lines. 61
32334462 2020
305
Accuracy of 18 F-FDG PET/CT in Detection of Neck Metastases of Oral Squamous Cell Carcinoma in Patients Without Large Palpable Lymph Nodes. 61
32057754 2020
306
Neck nodal recurrence and survival of clinical T1-2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: A meta-analysis. 61
32107184 2020
307
Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population. 61
32355279 2020
308
A Letter to Editor Regarding the Article "Identification of Differentially Expressed Proteins from Smokeless Tobacco Addicted Patients Suffering from Oral Squamous Cell Carcinoma". 61
32328975 2020
309
Detecting Bone Invasion of the Maxilla by Oral Squamous Cell Carcinoma: Diagnostic Accuracy of Preoperative Computed Tomography Versus Magnetic Resonance Imaging. 61
32445627 2020
310
SET protein modulates H4 histone methylation status and regulates miR-137 level in oral squamous cell carcinoma. 61
32267167 2020
311
Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis. 61
31750584 2020
312
Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma. 61
31982370 2020
313
Which Factors Affect the Long-Term Survival of Patients With Oral Squamous Cell Carcinoma With Distant Metastasis? 61
31765634 2020
314
Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194/miR-204 in vitro and in vivo. 61
32196598 2020
315
Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4. 61
31970286 2020
316
The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma. 61
31983439 2020
317
Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions. 61
32032477 2020
318
Luteolin-7-O-Glucoside Inhibits Oral Cancer Cell Migration and Invasion by Regulating Matrix Metalloproteinase-2 Expression and Extracellular Signal-Regulated Kinase Pathway. 61
32224968 2020
319
Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer. 61
32244515 2020
320
Nucleolar organizer regions in human oral verrucous carcinoma and adjacent lining epithelium. 61
32124655 2020
321
MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2. 61
32014885 2020
322
Atypical immunohistochemical patterns can complement the histopathological diagnosis of oral premalignant lesions. 61
32014614 2020
323
Basaloid squamous cell carcinoma: a 31-year retrospective study and analysis of 214 cases reported in the literature. 61
31912260 2020
324
Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer. 61
31909180 2020
325
Underexpression of SRSF3 and its target gene RBMX predicts good prognosis in patients with head and neck cancer. 61
32132325 2020
326
Evaluation of immunohistochemical expression of TWIST in oral epithelial dysplasia and squamous cell carcinoma. 61
32206058 2020
327
Development and Radiation Response Assessment in A Novel Syngeneic Mouse Model of Tongue Cancer: 2D Culture, 3D Organoids and Orthotopic Allografts. 61
32131500 2020
328
Role of tumor suppressor protein p16 in patients with oral lichen planus. 61
32521925 2020
329
Nerve growth factor-induced migration in oral and salivary gland tumour cells utilises the PI3K/Akt signalling pathway: Is there a link to perineural invasion? 61
31782565 2020
330
Bioactivity Guided Fractionation and Elucidation of Anti-Cancer Properties of Imperata Cylindrica Leaf Extracts. 61
32212797 2020
331
2-phenylethynesulfonamide inhibits growth of oral squamous cell carcinoma cells by blocking the function of heat shock protein 70. 61
32110810 2020
332
Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma. 61
32266176 2020
333
Diagnostic implications of miRNAs in Liquid Biopsy for Oral Squamous Cell Carcinoma (OSCC): Clinical validity and interpretation. 61
32171663 2020
334
Co-expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma. 61
31762177 2020
335
BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma. 61
32113162 2020
336
The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction. 61
31950224 2020
337
Nuclear Magnetic Resonance Metabolomics Biomarkers for Identifying High Risk Patients with Extranodal Extension in Oral Squamous Cell Carcinoma. 61
32235493 2020
338
Upregulation of Circular RNA circATRNL1 to Sensitize Oral Squamous Cell Carcinoma to Irradiation. 61
32032888 2020
339
Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. 61
32183030 2020
340
Down-regulation of hsa_circ_0092125 is related to the occurrence and development of oral squamous cell carcinoma. 61
31427049 2020
341
Prevalence of EBV, CMV, and HPV in oral squamous cell carcinoma patients in the Pakistani population. 61
32219873 2020
342
miRNA-101 Targets TGF-βR1 to Retard the Progression of Oral Squamous Cell Carcinoma. 61
31831099 2020
343
Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. 61
31570856 2020
344
NUDT1: A potential independent predictor for the prognosis of patients with oral squamous cell carcinoma. 61
31732994 2020
345
"Aberrant sialylation plays a significant role in oral squamous cell carcinoma progression". 61
31747460 2020
346
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. 61
32206709 2020
347
MicroRNA-129-5p represses the growth and aggressiveness of oral squamous cell carcinoma via suppressing HMGB1. 61
32133766 2020
348
MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production. 61
31814213 2020
349
A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation. 61
32165139 2020
350
HSP105 expression in oral squamous cell carcinoma: Correlation with clinicopathological features and outcomes. 61
32128880 2020
351
LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150. 61
32196599 2020
352
Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma. 61
32171289 2020
353
Identification of a six-gene prognostic signature for oral squamous cell carcinoma. 61
31538341 2020
354
Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. 61
32245251 2020
355
Epstein-Barr Virus Infection of Oral Squamous Cells. 61
32188127 2020
356
LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer. 61
31899825 2020
357
Troglitazone, a Selective Ligand for PPARγ, Induces Cell-cycle Arrest in Human Oral SCC Cells. 61
32132021 2020
358
Neutrophil extracellular traps (NETs) formation induced by TGF-β in oral lichen planus - Possible implications for the development of oral cancer. 61
31882256 2020
359
Assessment of surgical tumor-free resection margins in fresh squamous-cell carcinoma resection specimens of the tongue using a clinical MRI system. 61
32119170 2020
360
ICG-Guided Sentinel Lymph Node Sampling during Robotic Retroauricular Neck Dissection in cN0 Oral Cancer. 61
32043908 2020
361
Differential in vitro sensitivity of oral precancerous and squamous cell carcinoma cell lines to 5-aminolevulinic acid-mediated photodynamic therapy. 61
31479802 2020
362
Changes of serum miR-223-3p in patients with oral cancer treated with TPF regimen and the prognosis. 61
32194755 2020
363
Malignancy prediction among tissues from Oral SCC patients including neck invasions: a 1H HRMAS NMR based metabolomic study. 61
32162079 2020
364
Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition. 61
32284792 2020
365
S-seco-porphyrazine as a new member of the seco-porphyrazine family - Synthesis, characterization and photocytotoxicity against cancer cells. 61
32044518 2020
366
An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. 61
31987131 2020
367
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT. 61
32198613 2020
368
Investigation of Surgical Site Infections and Bacteria Detected Following Neck Dissection in Patients with Oral Cancer. 61
32074584 2020
369
The role of Candida albicans candidalysin ECE1 gene in oral carcinogenesis. 61
32170981 2020
370
H19 lncRNA: Roles in tumorigenesis. 61
31855739 2020
371
miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review. 61
31884798 2020
372
CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells. 61
32194746 2020
373
Suture line recurrence and oral squamous cell carcinoma: A viewpoint. 61
32165140 2020
374
Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients. 61
31839407 2020
375
Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma. 61
32235327 2020
376
Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. 61
32184381 2020
377
Exploring the long noncoding RNAs-based biomarkers and pathogenesis of malignant transformation from dysplasia to oral squamous cell carcinoma by bioinformatics method. 61
31343435 2020
378
MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway. 61
32171324 2020
379
Loss of S100A14 expression at the tumor-invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma. 61
32202693 2020
380
Long non-coding RNA RBM5-AS1 promotes the aggressive behaviors of oral squamous cell carcinoma by regulation of miR-1285-3p/YAP1 axis. 61
31869662 2020
381
Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma. 61
31762107 2020
382
Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma. 61
32115621 2020
383
Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells. 61
32188144 2020
384
Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts. 61
31270582 2020
385
Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter. 61
32017381 2020
386
Clinical Spectrum, Pattern, and Level-Wise Nodal Involvement Among Oral Squamous Cell Carcinoma Patients - Audit of 945 Oral Cancer Patient Data. 61
32205977 2020
387
Response to nivolumab combining radiotherapy and nimotuzumab in metastatic oral squamous cell carcinoma patient with strong PD-L1 expression: a case report. 61
32355846 2020
388
Terminalia bellirica extract induces anticancer activity through modulation of apoptosis and autophagy in oral squamous cell carcinoma. 61
31877368 2020
389
MIR4435-2HG regulates cancer cell behaviors in oral squamous cell carcinoma cell growth by upregulating TGF-β1. 61
32016787 2020
390
LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p. 61
32141551 2020
391
Mesenchymal stem cell transplantation attenuates growth of chemotherapy treated oral squamous cell carcinoma in an animal model. 61
32107794 2020
392
Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. 61
32093285 2020
393
circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. 61
32041942 2020
394
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma. 61
32057110 2020
395
Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma. 61
31660637 2020
396
Assessing Knowledge, Attitude and Practices for Oral Squamous Cell Carcinoma among Health Care Professionals in Princess Nourah University, Riyadh, KSA. 61
32102536 2020
397
Circular RNA hsa_circ_0011946 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA. 61
32096152 2020
398
Oral squamous cell carcinoma involving the maxillae: Factors affecting local recurrence and the value of salvage treatment for overall survival. 61
32101351 2020
399
Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-mediated Pathway in Oral Squamous Cell Carcinoma. 61
32050534 2020
400
Decreased Cytoplasmic Expression of ADAMTS14 Is Correlated with Reduced Survival Rates in Oral Squamous Cell Carcinoma Patients. 61
32102222 2020
401
Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma. 61
31730755 2020
402
A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation. 61
32015424 2020
403
A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis. 61
32436348 2020
404
Potency of Pfeiffer's Crystallization to Analyze Oral Leukoplakia and Squamous Cell Carcinoma. 61
32102533 2020
405
Mutual impact of clinically translatable near-infrared dyes on photoacoustic image contrast and in vitro photodynamic therapy efficacy. 61
32112541 2020
406
Ndrg1 Deficiency is associated with Regional Metastasis in Oral Cancer by inducing Epithelial-Mesenchymal transition. 61
32112078 2020
407
Natriuretic peptide system expression in murine and human submandibular salivary glands: a study of the spatial localisation of ANB, BNP, CNP and their receptors. 61
31722080 2020
408
Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib. 61
32106632 2020
409
Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection. 61
31304591 2020
410
The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation. 61
31857698 2020
411
Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ. 61
31442551 2020
412
Clinical significance of serum melatonin in predicting the severity of oral squamous cell carcinoma. 61
31966079 2020
413
Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. 61
31706945 2020
414
Is toombak a risk factor for oral leukoplakia and oral squamous cell carcinoma ? A systematic review. 61
31436350 2020
415
RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma. 61
31309556 2020
416
Anti-Cancer Effects of Traditional Medicinal Herbs on Oral Squamous Cell Carcinoma. 61
32102527 2020
417
The necessity of level IIb dissection for clinically negative neck oral squamous cell carcinoma. 61
32061708 2020
418
A novel sentinel lymph node approach in oral squamous cell carcinoma. 61
32053068 2020
419
Role of Toll like receptor in progression and suppression of oral squamous cell carcinoma. 61
32477468 2020
420
Fucoidan affects oral squamous cell carcinoma cell functions in vitro by regulating FLNA-derived circular RNA. 61
31495936 2020
421
Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis. 61
32041570 2020
422
Expression of inositol polyphosphate 4-phosphatase type II and the prognosis of oral squamous cell carcinoma. 61
32027770 2020
423
Clinicopathological study of involvement of the submandibular gland in oral squamous cell carcinoma. 61
31864860 2020
424
Expression and clinicopathologic significance of coxsackie-adenovirus receptor in oral squamous cell carcinoma. 61
31606425 2020
425
[Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression]. 61
32037759 2020
426
Value of SUVmax for the Prediction of Bone Invasion in Oral Squamous Cell Carcinoma. 61
32024247 2020
427
Butyrate Decreases ICAM-1 Expression in Human Oral Squamous Cell Carcinoma Cells. 61
32121422 2020
428
Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial. 61
32372215 2020
429
"Search less, verify more"-Reviewing salivary biomarkers in oral cancer detection. 61
32027406 2020
430
Improving oral cavity cancer diagnosis and treatment with fluorescence molecular imaging. 61
32072691 2020
431
Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma. 61
32113465 2020
432
Anti-p53 Autoantibody Detection in Automatic Glass Capillary Immunoassay Platform for Screening of Oral Cavity Squamous Cell Carcinoma. 61
32054134 2020
433
Perinerural, lymphovascular and depths of invasion in extrapolating nodal metastasis in oral cancer. 61
31139977 2020
434
Aberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCC. 61
31338836 2020
435
MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2. 61
31918270 2020
436
Log Odds of Positive Lymph Nodes is Not Superior to the Number of Positive Lymph Nodes in Predicting Overall Survival in Patients With Oral Squamous Cell Carcinomas. 61
31705864 2020
437
Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus. 61
31828562 2020
438
Risk of second primary cancer in oral squamous cell carcinoma. 61
32057158 2020
439
A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis. 61
32039930 2020
440
Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis. 61
32009633 2020
441
Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review. 61
32054041 2020
442
[Expression and significance of Ki-67, PI3K and Beclin1 in oral squamous cell carcinoma]. 61
32524126 2020
443
WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression. 61
31666682 2020
444
The Role of Carcinogenesis-Related Biomarkers in the Wnt Pathway and Their Effects on Epithelial-Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma. 61
32121061 2020
445
Inhibition effect of miR-150 on the progression of oral squamous cell carcinoma by data analysis model based on independent sample T-test. 61
32210677 2020
446
Diagnostic utility of touch imprint cytology for intraoperative assessment of surgical margins and sentinel lymph nodes in oral squamous cell carcinoma patients using four different cytological stains. 61
31675175 2020
447
MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6. 61
31812760 2020
448
[Effect of the focal adhesion kinase inhibitor TAE226 on the epithelial-mesenchymal transition in human oral squamous cell carcinoma cell line]. 61
32037761 2020
449
CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy. 61
32035907 2020
450
Development and validation of a multivariable prediction model for the identification of occult lymph node metastasis in oral squamous cell carcinoma. 61
32057148 2020
451
Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response. 61
32082486 2020
452
Preoperative intra-arterial chemotherapy with docetaxel, cisplatin, and peplomycin combined with intravenous chemotherapy using 5-fluorouracil for oral squamous cell carcinoma. 61
32070653 2020
453
MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway. 61
31680452 2020
454
Expression of Concern: The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma. 61
32287309 2020
455
CCHE1 accelerated the initiation of oral squamous cell carcinoma through enhancing PAK2 expression by sponging miR-922. 61
31981240 2020
456
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model. 61
32382550 2020
457
Erratum: Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration - Erratum. 61
32194802 2020
458
lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway. 61
32494159 2020
459
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. 61
31704611 2020
460
Co-expression of HIF-1 and TLR3 is associated with poor prognosis in oral squamous cell carcinoma. 61
32055274 2020
461
Identification and Validation of Novel Long Non-coding RNA Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma. 61
32351944 2020
462
Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway. 61
32099325 2020
463
Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study. 61
32019121 2020
464
WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling. 61
32174831 2020
465
LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma. 61
32021271 2020
466
Evaluation of circulating serum 3 types of microRNA as biomarkers of oral squamous cell carcinoma; A pilot study. 61
31483888 2020
467
p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation. 61
31996896 2020
468
Association of Helicobacter pylori with oral potentially malignant disorders and oral squamous cell carcinoma-a systematic review and meta-analysis. 61
31707627 2020
469
Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma. 61
31907776 2020
470
Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. 61
31902091 2020
471
Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients. 61
32528893 2020
472
Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1. 61
31746368 2020
473
Rho GTPases are Involved on Regulation of Cytodifferentiation of SCC-4 Oral Squamous Cell Carcinoma Cell Line: A Preliminary Study. 61
31983155 2020
474
MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma. 61
31970774 2020
475
Anti-Proliferative Role of the Tyrosine Kinase Inhibitors TKI-258 on Oral Squamous Cell Carcinoma In Vitro. 61
32053087 2020
476
The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma. 61
32083004 2020
477
Further Quantitative Structure-Cytotoxicity Relationship Analysis of 3-Styrylchromones. 61
31892556 2020
478
DEC1: a potential biomarker of malignant transformation in oral leukoplakia. 61
32578762 2020
479
Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions. 61
31025711 2020
480
Squamous cell carcinoma related with dental implants. A clinical cases report. 61
31976051 2020
481
Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma. 61
31062130 2020
482
Bibliographic Analysis of Oral Precancer and Cancer Research Papers from Saudi Arabia. 61
31983157 2020
483
CD146 expression in oral lichen planus and oral cancer. 61
31102047 2020
484
Prevalence of oral cancer and oral epithelial dysplasia among North Indian population: A retrospective institutional study. 61
32508454 2020
485
Qualitative expression of hypoxia-inducible factor-1α in malignant transformation of oral submucous fibrosis: An immunohistochemical study. 61
32508457 2020
486
Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression. 61
31793175 2020
487
Emerging functions and clinical applications of exosomes in human oral diseases. 61
32489584 2020
488
p38 Expression and Modulation of STAT3 Signaling in Oral Cancer. 61
29564744 2020
489
Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC. 61
30406875 2020
490
Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study. 61
32508447 2020
491
Quantitative analysis of tumor-associated tissue eosinophils and tumor-associated blood eosinophils in oral squamous cell carcinoma. 61
32508461 2020
492
Immunoexpression of p53 in histologically negative surgical margins adjacent to oral squamous cell carcinoma: A preliminary study. 61
32508474 2020
493
Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma. 61
31683463 2020
494
REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density. 61
31897156 2020
495
Postoperative adjuvant therapy for patients with loco-regionally advanced oral squamous cell carcinoma who are at high risk of recurrence. 61
31926824 2020
496
Overexpression of Malic Enzyme 2 Indicates Pathological and Clinical Significance in Oral Squamous Cell Carcinoma. 61
32218701 2020
497
Prognosis of oral squamous cell carcinoma with perineural invasion: A comparative study of classification types. 61
31677332 2020
498
Co-occurrence of Warthin's tumor with oral squamous cell carcinoma - Overlapping risk factors and implications. 61
31648865 2020
499
Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. 61
32399208 2020
500
Interleukin-1 (IL-1) Immunohistochemistry Assay in Oral Squamous Cell Carcinoma. 61
31939170 2020
501
Alpinetin Inhibits Oral Squamous Cell Carcinoma Proliferation via miR-211-5p Upregulation and Notch Pathway Deactivation. 61
31403340 2020
502
AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression. 61
32012175 2020
503
Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma. 61
32351881 2020
504
The LncRNA H19 rs217727 Polymorphism Is Associated with Oral Squamous Cell Carcinoma Susceptibility in Iranian Population. 61
32337223 2020
505
Clinicopathological Features of Programmed Cell Death-ligand 1 Expression in Patients with Oral Squamous Cell Carcinoma. 61
32337367 2020
506
Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma. 61
31996191 2020
507
Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma. 61
32092078 2020
508
Hsa_circ_0086414 Might Be a Diagnostic Biomarker of Oral Squamous Cell Carcinoma. 61
31933490 2020
509
LncRNA LUADT1 Promotes Oral Squamous Cell Carcinoma Cell Proliferation by Regulating miR-34a/GAS1 Axis. 61
32494204 2020
510
Characterization of perineural invasion in different histological grades and variants of oral squamous cell carcinoma. 61
32508449 2020
511
Expression of metallothionein in oral squamous cell carcinoma: A systematic review. 61
32508463 2020
512
Galectin-1 expression in oral squamous cell carcinoma: An immunohistochemical study. 61
32508476 2020
513
Epithelial-mesenchymal transition in oral squamous cell carcinoma: An insight into molecular mechanisms and clinical implications. 61
32508481 2020
514
Efficient miRNA Inhibitor Delivery with Graphene Oxide-Polyethylenimine to Inhibit Oral Squamous Cell Carcinoma. 61
32210552 2020
515
A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors. 61
31902496 2020
516
Erianin Induces Apoptosis and Autophagy in Oral Squamous Cell Carcinoma Cells. 61
31903779 2020
517
Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. 61
31529626 2020
518
Proline-Dependent Induction of Apoptosis in Oral Squamous Cell Carcinoma (OSCC)-The Effect of Celecoxib. 61
31935820 2020
519
DUB3 Facilitates Growth and Inhibits Apoptosis Through Enhancing Expression of EZH2 in Oral Squamous Cell Carcinoma. 61
32110043 2020
520
Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways. 61
32158195 2020
521
Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma. 61
32158692 2020
522
Aberrant Expression and Subcellular Localization of PER2 Promote the Progression of Oral Squamous Cell Carcinoma. 61
32185221 2020
523
Role and Mechanism of LIF in Oral Squamous Cell Carcinoma Progression. 61
31973037 2020
524
TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis. 61
32174793 2020
525
MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4. 61
31829025 2020
526
Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis. 61
31424263 2020
527
MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L. 61
31942199 2020
528
Pattern-Corrected Mitotic Activity Index (PMAI): A Novel Prognosticator of Oral Squamous Cell Carcinoma. 61
31310321 2020
529
Inhibition of matrix metalloproteinase-2 modulates malignant behaviour of oral squamous cell carcinoma cells. 61
31925966 2020
530
Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma. 61
31983161 2020
531
MiR-124a suppressed cell migration and invasion via AGR2 in oral squamous cell carcinoma. 61
31985183 2020
532
Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics. 61
31602722 2020
533
The prevalence of oral high-risk HPV infection in Indonesian oral squamous cell carcinoma patients. 61
31670871 2020
534
Junction plakoglobin, a potential prognostic marker of oral squamous cell carcinoma, promotes proliferation, migration and invasion. 61
31420988 2020
535
Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p. 61
32016969 2020
536
Propofol facilitates migration and invasion of oral squamous cell carcinoma cells by upregulating SNAI1 expression. 61
31811855 2020
537
Analysis of risk factors for multiple primary oral squamous cell carcinoma: a cohort study. 61
31903501 2020
538
Metformin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells through P38MAPK signaling pathway. 61
31992033 2020
539
Functional Landscape of Dysregulated MicroRNAs in Oral Squamous Cell Carcinoma: Clinical Implications. 61
32547936 2020
540
Immune Landscape of the B7 and TNFR Families in Oral Squamous Cell Carcinoma. 61
32548602 2020
541
Knockdown of LINC00662 represses AK4 and attenuates radioresistance of oral squamous cell carcinoma. 61
32549791 2020
542
Assessment of Proliferative Index Between the Tumor Margin, Center of Tumor, and the Invasive Tumor Front of Oral Squamous Cell Carcinoma With the Help of Mcm-2: An Immunohistochemical Study. 61
30359334 2020
543
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection. 61
32292795 2020
544
Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. 61
31739192 2020
545
DMBA-Induced Oral Carcinoma in Syrian Hamster: Increased Carcinogenic Effect by Dexamethasone Coexposition. 61
32149076 2020
546
Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan. 61
31571325 2020
547
Cancer stem cells: A comprehensive review on identification and therapeutic implications. 61
32508482 2020
548
Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas. 61
32064037 2020
549
Oral Cancer: Genetics and the Role of Precision Medicine. 61
31757309 2020
550
DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation. 61
31931863 2020
551
Antitumor Activity of Ficus deltoidea Extract on Oral Cancer: An In Vivo Study. 61
32104177 2020
552
Cytopathological tests for early detection of oral carcinogenesis. 61
30913094 2020
553
Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42. 61
31897232 2020
554
Intraoperative Surgical Margin Clearance - Correlation of Touch Imprint Cytology, Frozen Section Diagnosis, and Histopathological Diagnosis. 61
32002379 2020
555
The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis. 61
31837884 2020
556
Adequacy of surgical margins in oral cancer patients with respect to various types of reconstruction. 61
31956618 2020
557
Potential Salivary mRNA Biomarkers for Early Detection of Oral Cancer. 61
31963366 2020
558
Determination and validation of mycophenolic acid by a UPLC-MS/MS method: Applications to pharmacokinetics and tongue tissue distribution studies in rats. 61
31855839 2020
559
Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. 61
31997506 2020
560
Impact of Epigenetic alterations in the development of oral diseases. 61
31942842 2020
561
Dental Implants in Patients with Oral Lichen Planus: A Systematic Review. 61
32012782 2020
562
Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study. 61
32508443 2020
563
Comparative evaluation of staining efficacy of calcofluor white and acridine orange for detection of Candida species using fluorescence microscopy - A prospective microbiological study. 61
32508453 2020
564
LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression. 61
31731187 2020
565
Predicting STAT1 as a prognostic marker in patients with solid cancer. 61
32426049 2020
566
First case report of tongue squamous cell carcinoma in a neurofibromatosis type 1 patient and review of pathogenesis of carcinoma in neurofibromatosis type 1. 61
32031137 2020
567
Progress in the study of long noncoding RNA in tongue squamous cell carcinoma. 61
31611036 2020
568
The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. 61
32231730 2020
569
Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients. 61
32547888 2020
570
Expression and function of FRA1 protein in tumors. 61
31612408 2020
571
High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma. 61
32440097 2020
572
Secondary Squamous Cell Carcinoma of the Oral Cavity after Nasopharyngeal Carcinoma. 61
31163959 2020
573
Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway. 61
31452270 2020
574
RP11-284F21.9 promotes oral squamous cell carcinoma development via the miR-383-5p/MAL2 axis. 61
31397491 2020
575
RP11-874J12.4 promotes oral squamous cell carcinoma tumorigenesis via the miR-19a-5p/EBF1 axis. 61
32004389 2020
576
The significance of PA28γ and U2AF1 in oral mucosal carcinogenesis. 61
31605415 2020
577
Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma. 61
31983189 2020
578
Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide. 61
31309636 2020
579
Circular RNA HIPK3: A Key Circular RNA in a Variety of Human Cancers. 61
32500032 2020
580
Cisplatin Induced the Expression of SEI1 (TRIP-Br1) Oncogene in Human Oral Squamous Cancer Cell Lines. 61
31892553 2020
581
DLEU1: A Functional Long Noncoding RNA in Tumorigenesis. 61
31969095 2020
582
CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma. 61
31880289 2020
583
Study of Hypoxia-inducible factor-2α expression in the malignant transformation of Oral submucous fibrosis. 61
32508445 2020
584
Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells. 61
31765243 2020
585
Expression of RAD51 and Its Clinical Impact in Oral Squamous Cell Carcinoma. 61
32190537 2020
586
c-Fos in oral squamous cell carcinoma. 61
32277693 2020
587
Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma. 61
31989718 2020
588
Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis. 61
32117620 2020
589
MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. 61
31981257 2020
590
Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65. 61
32021276 2020
591
Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin. 61
32411595 2020
592
Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. 61
32294127 2020
593
Fibroblast Activation Protein (FAP) Overexpression Induces Epithelial-Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma by Down-Regulating Dipeptidyl Peptidase 9 (DPP9). 61
32273729 2020
594
Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway. 6